Cargando…

The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer

Advances in personalized medicine are supported by companion diagnostic molecular tests. Testing accuracy is critical for selecting patients for optimal therapy and reducing treatment-related toxicity. We assessed the clinical and economic impact of inaccurate test results between laboratory develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Mindy M., Palma, John F., Scudder, Sidney, Poulios, Nick, Liesenfeld, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618152/ https://www.ncbi.nlm.nih.gov/pubmed/28657610 http://dx.doi.org/10.3390/jpm7030005

Ejemplares similares

Budget Impact Analysis of EGFR Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece
por: Cheng, Mindy, et al.
Publicado: (2020)

Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer
por: Ho, Hsiang-Ling, et al.
Publicado: (2022)

Modified Early Warning Scores: inaccurate summation or inaccurate assignment of score?
por: Edwards, M, et al.
Publicado: (2010)

Inaccurate models for mixtures.
por: Putzrath, R M
Publicado: (2001)

Inaccurate Clinical Thermometers
Publicado: (1905)

Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancer
por: Wei, Bing, et al.
Publicado: (2014)

Sense and sensitivity: can an inaccurate test be better than no test at all?
por: Pugh, Jonathan, et al.
Publicado: (2022)

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
por: Jung, Hyun Ae, et al.
Publicado: (2020)

Endosulfan’s Effects: Inaccurate Data
por: Indulkar, A. S.
Publicado: (2004)

Political violence and inaccurate metaperceptions
por: Lees, Jeffrey
Publicado: (2022)

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer
por: Bozorgmehr, Farastuk, et al.
Publicado: (2021)

Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer
por: Wang, Youping, et al.
Publicado: (2023)

PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment
por: Chang, Cheng-Yu, et al.
Publicado: (2021)

Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis
por: Zeng, Xiaohui, et al.
Publicado: (2014)

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
por: Le, Xiuning, et al.
Publicado: (2023)

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer
por: Russo, Alessandro, et al.
Publicado: (2017)

Inaccurate Models for Mixtures: Kortenkamp's Response
por: Kortenkamp, A
Publicado: (2001)

Break-Induced Replication Is Highly Inaccurate
por: Deem, Angela, et al.
Publicado: (2011)

The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer
por: Lewandowska, Marzena Anna, et al.
Publicado: (2015)

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
por: Le, Xiuning, et al.
Publicado: (2023)

Can we cure metastatic EGFR-mutated lung cancer today?
por: Christopoulos, Petros
Publicado: (2023)

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
por: Vyberg, Mogens, et al.
Publicado: (2015)

‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing
por: Ramdas, Kamalini, et al.
Publicado: (2020)

Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
por: Chantharasamee, J., et al.
Publicado: (2019)

Inaccurate Assessment of Canine Body Condition Score, Bodyweight, and Pet Food Labels: A Potential Cause of Inaccurate Feeding
por: Yam, Philippa S., et al.
Publicado: (2017)

Common errors and clinical guidelines for manual muscle testing: "the arm test" and other inaccurate procedures
por: Schmitt, Walter H, et al.
Publicado: (2008)

Metastatic Lung Adenocarcinoma Harboring an EGFR-Activating Mutation in a Heart Transplant Recipient
por: Zambrano Mendoza, Elizabeth, et al.
Publicado: (2017)

Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study
por: Cheng, Wen-Chien, et al.
Publicado: (2023)

Inaccurate Multilocus Sequence Typing of Acinetobacter baumannii
por: Castillo-Ramírez, Santiago, et al.
Publicado: (2019)

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
por: Soulières, D., et al.
Publicado: (2010)

Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea
por: Lim, Eun-A, et al.
Publicado: (2016)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR)
por: Singh, Charu
Publicado: (2014)

STRA6 Polymorphisms Are Associated With EGFR Mutations in Locally-Advanced and Metastatic Non-Small Cell Lung Cancer Patients
por: Muñiz-Hernández, Saé, et al.
Publicado: (2020)

Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib
por: Yanagisawa, Atsushi, et al.
Publicado: (2022)

Inaccurate nasopharyngeal testing in a patient with gastrointestinal COVID19: A case report
por: Ramaraj, Akila B., et al.
Publicado: (2021)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
por: Berz, David, et al.
Publicado: (2016)

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY
por: Nishio, Makoto, et al.
Publicado: (2020)

Borderline features are associated with inaccurate trait self-estimations
por: Morey, Leslie C
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o6mo5t9hphdje3eodm8b8kdah0